Isolated laryngeal myokymia: diagnosis and treatment.
Myokymia is an uncommon neuromuscular disorder that rarely affects the human larynx. No previous reports of isolated laryngeal myokymia are present in the literature, and as such, established treatment protocols are lacking. We report the first case of isolated laryngeal myokymia in a 48-year-old woman with no other neurological findings, and our successful results in initial treatment and maintenance therapy with focal intralaryngeal injections of botulinum toxin A.
Sedgh
Jacob
J
Department of Otolaryngology, University of Pittsburgh Voice Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15219, USA.
Statham
Melissa M
MM
Munin
Michael C
MC
Small
George
G
Rosen
Clark A
CA
D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007818:Laryngeal Diseases / Q000175:diagnosis* / Q000188:drug therapy*; D008875:Middle Aged; D020385:Myokymia / Q000175:diagnosis* / Q000188:drug therapy*; D009465:Neuromuscular Agents / Q000627:therapeutic use*
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A